Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: Two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation

Cancer Detection and Prevention

Volumn 28, Issue 6, 2004, Pages 443-452

  Narayanan, Narayanan K ^a,b   Narayanan, Bhagavathi A ^a   Nixon, Daniel W ^a  

^a Inst Cancer Prev 1 Dana Rd V   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2D SDS PAGE; cDNA microarray; PGAM B; Phosphoglycerate mutase B glycolysis; Prostate cancer; PS phosphatidylserine; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; PHOSPHOGLYCERATE MUTASE; RESVERATROL; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECT; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSTATE TUMOR;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MALE; MASS SPECTROMETRY; PHOSPHOGLYCERATE MUTASE; PROSTATIC NEOPLASMS; STILBENES; TUMOR CELLS, CULTURED;

EID: 9644266677     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdp.2004.08.009     Document Type: Article

References (29)

1. A. Jemal, R.C. Tiwari, and T. Murray Cancer statistics 2004 CA Cancer J Clin 54 2004 8 29
2. H. Templeton The management of prostate cancer Nurs Stand 17 2003 45 53
3. F.L. Meyskens Jr Re: cancer chemoprevention: progress and promise J Natl Cancer Inst 91 1999 563 565
4. J.M. Pezzuto Plant-derived anticancer agents Biochem Pharmacol 53 1997 121 133
5. H. Lu, X. Meng, and C.S. Yang Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate Drug Metab Dispos 31 2003 572 579
6. H. Lu, X. Meng, and C. Li Glucuronides of tea catechins: enzymology of biosynthesis and biological activities Drug Metab Dispos 31 2003 452 461
7. A.N. Kong, R. Yu, and V. Hebbar Signal transduction events elicited by cancer prevention compounds Mutat Res 480-481 2001 231 241
8. M. Jang, L. Cai, and G.O. Udeani Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
9. B.A. Narayanan, G.G. Re, and N.K. Narayanan Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets Int J Cancer 104 2003 204 212
10. M.I. Koukourakis, A. Giatromanolaki, and E. Sivridis Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors Tumor Biol 24 2003 199 202
11. M.G. Lee, and P.L. Pedersen Glucose metabolism in cancer: importance of transcription factor-DNA interactions within a short segment of the proximal region of the type II hexokinase promoter J Biol Chem 278 2003 41047 41058
12. U. Haberkorn, S.I. Ziegler, and F. Oberdorfer FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models Nucl Med Biol 21 1994 827 834
13. D. Rivenzon-Segal, S. Boldin-Adamsky, D. Seger, R. Seger, and H. Degani Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer Int J Cancer 107 2003 177 182
14. P.H. O'Farrell High-resolution two-dimensional electrophoresis of proteins J Biol Chem 250 1975 4007 4021
15. L.G. Boros, D.J. Brackett, and G.G. Harrigan Metabolic biomarker and kinase drug target discovery in cancer using stable isotope-based dynamic metabolic profiling (SIDMAP) Curr Cancer Drug Targets 3 2003 445 453
16. R.A. Gatenby, and E.T. Gawlinski The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models Cancer Res 63 2003 3847 3854
17. K.L. Meehan, J.W. Holland, and H.J.S. Dawkins Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer Prostate 50 2002 54 63
18. M. Ahram, C.J. Best, and M.J. Flaig Proteomic analysis of human prostate cancer Mol Carcinog 33 2002 9 15
19. J.D. Wulfkuhle, K.C. McLean, C.P. Paweletz, and D.C. Sgroi New approaches to proteomic analysis of breast cancer Proteomics 1 2001 1205 1215
20. M. Verma, G.L. Wright Jr, S.M. Hanash, R. Gopal-Srivastava, and S. Srivastava Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers Ann N Y Acad Sci 945 2001 103 115
21. A. Waghray, F. Feroze, and M.S. Schober Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis Proteomics 1 2001 1327 1338
22. H.J. Issaq, T.P. Conrads, G.M. Janini, and T.D. Veenstra Methods for fractionation, separation and profiling of proteins and peptides Electrophoresis 23 2002 3048 3061
23. E.S. Leman, and R.H.J. Getzenberg Nuclear matrix proteins as biomarkers in prostate cancer Cell Biochem 86 2002 213 223
24. D.E. Graham, H.M. Xu, and R.H. White A divergent archaeal member of the alkaline phosphatase binuclear metalloenzyme superfamily has phosphoglycerate mutase activity FEBS Lett 517 2002 190 194
25. F. Boraldi, L. Bini, and S. Liberatori Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages Proteomics 3 2003 917 929
26. D.J. Rigden, E. Lamani, L.V. Mello, J.E. Littlejohn, and M.J. Jedrzejas Insights into the catalytic mechanism of cofactor-independent phosphoglycerate mutase from X-ray crystallography, simulated dynamics and molecular modeling J Mol Biol 328 2003 909 920
27. L.W. Wattenberg Chemoprevention of cancer Cancer Res 45 1985 1 8
28. N. Durany, J. Joseph, and O.M. Jimenez Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma Br J Cancer 82 2000 20 27
29. J.S. Bertram, L.N. Kolonel, and F.L. Meyskens Jr Rationale and strategies for chemoprevention of cancer in humans Cancer Res 47 1987 3012 3031